ATBAT
ATBAT
Anticoagulant Therapy with Bivalirudin to Assist in the performance of PCI in patients with heparin-induced Thrombocytopenia. A trial at Duke (US) which was to evaluate the safety of bivalirudin as an alternative anticoagulant in patients with heparin-induced thrombocytopenia (HIT) or HIT plus thrombosis syndrome (HITTS) undergoing PCI.Conclusion ATBAT was to have been completed in 2003.